iBio Faces Increased Losses and Revenue Decline Amid Market Challenges

New York, Sunday, 7 September 2025.
iBio, Inc. reported a $18.4 million net loss for 2025, a 19% increase from last year, with earnings per share at -$1.75. Revenue is expected to decline by 172% annually, posing significant risks.